Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487. Health Law May 2010 Silicone Breast Implant Litigation Kristin E. Schleiter, JD, LLM Virtual Mentor. 2010;12(5):389-394. doi: 10.1001/virtualmentor.2010.12.5.hlaw1-1005.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487.
Health Law May 2010 Silicone Breast Implant Litigation Kristin E. Schleiter, JD, LLM Virtual Mentor. 2010;12(5):389-394. doi: 10.1001/virtualmentor.2010.12.5.hlaw1-1005.